Patents by Inventor Rangachari Narashimhan

Rangachari Narashimhan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
    Patent number: 8404217
    Abstract: Formulations are provided for pulmonary administration of an antifungal agent to a patient. Methods of using the formulations in the treatment of antifungal infections are also provided, including treatment of pulmonary aspergillosis with amphotericin B-containing formulations. Methods of manufacturing the formulations to achieve optimum properties are provided as well.
    Type: Grant
    Filed: July 22, 2005
    Date of Patent: March 26, 2013
    Assignee: Novartis AG
    Inventors: Thomas E. Tarara, Jeffry G. Weers, Michael A. Eldon, Rangachari Narashimhan, Andrew Clark
  • Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
    Publication number: 20060159625
    Abstract: Formulations are provided for pulmonary administration of an antifungal agent to a patient. Methods of using the formulations in the treatment of antifungal infections are also provided, including treatment of pulmonary aspergillosis with amphotericin B-containing formulations. Methods of manufacturing the formulations to achieve optimum properties are provided as well.
    Type: Application
    Filed: July 22, 2005
    Publication date: July 20, 2006
    Applicant: Nektar Therapeutics
    Inventors: Thomas Tarara, Jeffry Weers, Michael Eldon, Rangachari Narashimhan, Andrew Clark